肝细胞癌的当前和未来的辅助疗法
Jeng-Shiun Du1,2, Shih-Hsien Hsu3,4, Shen-Nien Wang3,5,6
1Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
Cancers
|April 13, 2024
概括
手术后肝细胞癌 (HCC) 的复发率很高. 本综述探讨了风险因素和辅助疗法,如向疗法和免疫疗法,以改善肝癌患者的生存结果.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 手术瘤学手术瘤学
背景情况:
- 肝细胞癌 (HCC) 是最常见的初级肝癌,其特点是高侵袭性和复发率.
- 目前的化疗等治疗方法的疗效有限,治疗方案包括手术切除或肝移植.
- 即使在移植 (20%在5年) 和切除 (70%在5年) 之后,显著的复发率仍然存在,需要改进策略.
研究的目的:
- 审查与彻底手术切除后HCC复发相关的风险因素.
- 突出辅助疗法选择,旨在降低复发风险和提高生存率.
- 确定在优化HCC的辅助治疗方面进行进一步研究的领域.
主要方法:
- 文献综述侧重于肝细胞癌 (HCC) 复发.
- 对手术后HCC复发的危险因素的分析.
- 评估各种辅助治疗方式,包括局部,全身和其他方法.
主要成果:
- 手术切除 (70%在5年) 和肝移植 (20%在5年) 后HCC复发的高率强调需要改善管理.
- 辅助疗法,包括局部 (TACE,放射疗法),全身 (向疗法,免疫疗法) 和传统化疗,正在探索它们减轻复发的潜力.
- 该审查确定需要进一步研究,以完善这些辅助疗法的应用和有效性.
结论:
- 识别HCC复发的风险因素对于改善患者的治疗结果至关重要.
- 辅助疗法提供了潜在的策略,以减少HCC复发并提高切除后的存活率.
- 需要进行进一步的研究,以优化辅助疗法的使用,并最大限度地提高它们在预防HCC复发方面的益处.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360


